News
Talking blood cancers with Dr. Zohar Sachs
What are blood cancers? We sat down with MCC’s Zohar Sachs, MD, PhD to chat about all things blood cancers from signs and symptoms, to research happening here at the University of Minnesota. Dr. Sachs, alongside Taylor Kadlac and…
Masonic Cancer Center announces Spring 2024 internal grant awards
The Masonic Cancer Center, University of Minnesota recently announced the awarding of $230,000 in pilot grants through its Spring 2024 Internal Grant Program. Support for these grants is made available by the center through a variety of…
Talking translational research with Dr. Deepa Kolaseri and Dr. Manish Patel
Curious about how scientific discoveries become real-world therapies? Physician-scientist Manish Patel, DO, and Deepa Kolaseri, PhD, scientific director of translation chat about the journey of translational research from…
Uncovering the origins of a deadly canine cancer
Researchers from the University of Minnesota College of Veterinary Medicine (CVM) and the Masonic Cancer Center (MCC) have identified the likely cell of origin for canine hemangiosarcoma—one of the deadliest forms of cancer in dogs, with a…
New MCC-led study finds cell donor’s socioeconomic status shapes cancer treatment outcomes
Published in PNAS, a research team led by Masonic Cancer Center and University of Minnesota Medical School scientists demonstrated that the socioeconomic status (SES) of cell donors affects the health outcomes of blood cancer patients who…
MCC's Dr. Rahel Ghebre named new Associate Dean for Faculty Affairs
We are thrilled to announce that the Masonic Cancer Center's Dr. Rahel Ghebre has been named the new Associate Dean for Faculty Affairs in the U of M Medical School. Dr. Ghebre brings a wealth of experience and a visionary approach to this…
Masonic Cancer Center and Mayo Clinic partner to revolutionize individualized cancer treatment
Cancer is the second leading cause of disease-associated death in the U.S. Although more patients are living longer and higher-quality lives as cancer survivors, the most used cancer treatments can cause serious medical problems. These…
National working group featuring MCC scientists releases landmark ethical guidance for new portable MRI brain research
MRI, or magnetic resonance imaging, has transformed neuroscience research and medical diagnoses over the past 50 years. During that time, research participants and patients alike have had to travel to the scanner. With the aim of making…
Talking cancer survivorship with Dr. Tara Rick
June is National Cancer Survivors Month. This month we sat down with Tara Rick, PhD, PA-C, research associate in Cancer Survivorship and practicing physician assistant in Hematology and Oncology, to chat about cancer survivorship research…
Training the next generation of cancer doctors, researchers, and care providers
Equipping and exciting the next generation of health care professionals and researchers is a huge priority in cancer research and care. And at MCC, we’re doubling down on dedicating a large portion of our energy to STEM-related training…